Catalyst Healthcare Consulting President Nancy Bradish Myers has been elected Chair of the Board of the FDA Alumni Association (FDAAA). Her two-year term began on April 22, 2014. She succeeds Joseph Levitt as Chair; Charles Hoiberg will serve as Board Vice Chair.

“The FDA Alumni Association is a dynamic and vital organization. As Chair, I hope to bring a strategic vision as the organization continues to grow in size and relevance to its members and FDA,” Ms. Myers said.

“FDAAA’s mission is to ‘Serve Those Who Have Served.’ FDAAA is poised to launch and expand some very exciting programs that will support both US and international regulators, which will create significant new opportunities for alumni to get involved in philanthropic and other meaningful activities. I look forward to supporting all the hard work of my fellow association leaders,” she said.

“Overall, the goal for my tenure is to continue to find creative, impactful ways to add value for our current and future members, as well as support our colleagues still at FDA,” she said.

Ms. Myers has served in various positions within the association, including Vice Chair of the Executive Committee and Co-Chair of the Activities Committee. She is also active in FDAAA’s International Network. During her time at FDA, she served as senior strategic advisor in FDA’s Office of the Commissioner.

About Catalyst
Catalyst Healthcare Consulting, Inc. helps biopharma, medical device and combination product clients distill complex health care issues into meaningful commercial and philanthropic opportunities. We advise clients who have specific issues before the FDA, as well as those focused on longer-term relationships. Our expertise includes identifying novel regulatory pathways for cutting edge health care technologies, regulatory intelligence gathering designed to inform corporate strategy, and helping clients understand the current FDA regulatory environment.